Malignancies in systemic rheumatic diseases: A mini review.

Geng, Zhe; Ye, Cong; Zhu, Xiaojian

Geng, Zhe; Ye, Cong; Zhu, Xiaojian.

Affiliation

Geng Z; Department of Hematology, Central Hospital of Wuhan, Wuhan, China.
Ye C; Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhu X; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Front Immunol ; 14: 1095526, 2023.

Article in En | MEDLINE | ID: mdl-36926334

Subject(s)

Antirheumatic Agents; Neoplasms; Rheumatic Diseases; Humans; Quality of Life; Rheumatic Diseases/complications; Rheumatic Diseases/drug therapy; Antirheumatic Agents/therapeutic use; Inflammation/drug therapy; Neoplasms/epidemiology; Neoplasms/etiology; Neoplasms/drug therapy

Key words

disease-modifying anti-rheumatic drugs; malignancy; mechanism; rheumatic disease; risk

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Rheumatic Diseases / Antirheumatic Agents / Neoplasms Type of study: Etiology_studies Limits: Humans Language: En Journal: Front Immunol Year: 2023 Type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google